At a glance
- Originator Nonindustrial source; Novartis
- Developer Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Cancer in France (PO)
- 25 Jan 1994 Preclinical development for Cancer in France (PO)